AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2018
Dec 17, 2018
33003_dirs_2018-12-17_ad660cfb-a97a-4ff0-a5cd-f428f04a60fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-12-13
Reporting Person: Nagendran Sukumar (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-12-13 | Director Stock Option (Right to Buy) | $23.58 | A | 17240 | Acquired | 2028-12-13 | Common Stock (17240) | Direct |
Footnotes
F1: This option was granted on December 13, 2018 and vests as to one-third of the total number of shares on each of September 12, 2019, September 12, 2020, and September 12, 2021, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19